BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 27125440)

  • 1. Varicella-zoster virus: pathogenesis, incidence patterns and vaccination programs.
    Gabutti G; Franchi M; Maniscalco L; Stefanati A
    Minerva Pediatr; 2016 Jun; 68(3):213-25. PubMed ID: 27125440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.
    Ouwens MJ; Littlewood KJ; Sauboin C; Téhard B; Denis F; Boëlle PY; Alain S
    Clin Ther; 2015 Apr; 37(4):816-829.e10. PubMed ID: 25726457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
    Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varicella vaccination - the global experience.
    Wutzler P; Bonanni P; Burgess M; Gershon A; Sáfadi MA; Casabona G
    Expert Rev Vaccines; 2017 Aug; 16(8):833-843. PubMed ID: 28644696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspective on live varicella vaccine.
    Gershon AA; Katz SL
    J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccines against varicella-zoster virus (VZV)].
    Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
    Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunization of adults against varicella and herpes zoster].
    Hanslik T; Blanchon T; Alvarez FP
    Rev Med Interne; 2007 Mar; 28(3):166-72. PubMed ID: 17270316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One or two doses of live varicella virus-containing vaccines: Efficacy, persistence of immune responses, and safety six years after administration in healthy children during their second year of life.
    Henry O; Brzostek J; Czajka H; Leviniene G; Reshetko O; Gasparini R; Pazdiora P; Plesca D; Desole MG; Kevalas R; Gabutti G; Povey M; Innis B
    Vaccine; 2018 Jan; 36(3):381-387. PubMed ID: 29224964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunization against varicella and zoster].
    Floret D
    Bull Acad Natl Med; 2007 Jun; 191(6):1051-64; discussion 1064-7. PubMed ID: 18402164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes zoster in the context of varicella vaccination - An equation with several variables.
    Wutzler P; Casabona G; Cnops J; Akpo EIH; Safadi MAP
    Vaccine; 2018 Nov; 36(46):7072-7082. PubMed ID: 30309745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Güris D; Chaves SS; Schmid S; Seward JF;
    MMWR Recomm Rep; 2007 Jun; 56(RR-4):1-40. PubMed ID: 17585291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal varicella vaccine immunization in Japan.
    Yoshikawa T; Kawamura Y; Ohashi M
    Vaccine; 2016 Apr; 34(16):1965-70. PubMed ID: 26944711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.
    van Hoek AJ; Melegaro A; Gay N; Bilcke J; Edmunds WJ
    Vaccine; 2012 Feb; 30(6):1225-34. PubMed ID: 22119592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013.
    Hobbelen PH; Stowe J; Amirthalingam G; Miller L; van Hoek AJ
    J Infect; 2016 Sep; 73(3):241-53. PubMed ID: 27283754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella zoster vaccines.
    Creed R; Satyaprakash A; Ravanfar P
    Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil.
    Scotta MC; Paternina-de la Ossa R; Lumertz MS; Jones MH; Mattiello R; Pinto LA
    Vaccine; 2018 Jan; 36(2):280-284. PubMed ID: 29198917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation.
    Bakker KM; Eisenberg MC; Woods RJ; Martinez ME
    BMC Med; 2022 Oct; 20(1):387. PubMed ID: 36209074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.